A Study to Assess a PI3Kδ Inhibitor (IOA-244) in Patients With Metastatic Cancers
iOnctura
iOnctura
Mayo Clinic
City of Hope Medical Center
Wake Forest University Health Sciences
Massachusetts General Hospital
University of Louisville
Alliance for Clinical Trials in Oncology
City of Hope Medical Center
Indiana University
Indiana University
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Northwestern University
Northwestern University
Rutgers, The State University of New Jersey